246 related articles for article (PubMed ID: 9464817)
21. Serum interferon gamma levels in autoimmune thyroid disease.
Matsubayashi S; Kasuga Y; Sakatsume Y; Akasu F; Volpé R
Clin Invest Med; 1990 Oct; 13(5):271-4. PubMed ID: 2125901
[TBL] [Abstract][Full Text] [Related]
22. [Organ-specific autoimmune diseases and cytokines].
Hidaka Y; Amino N
Rinsho Byori; 1999 Apr; 47(4):335-9. PubMed ID: 10340007
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
Selenkow HA; Wyman P; Allweiss P
Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the role of Th0 and Th1 clones in autoimmune thyroid disease by use of Hu-SCID chimeras.
Fisfalen ME; Soltani K; Kaplan E; Palmer EM; van Seventer GA; Straus FH; Diaz M; Ober C; DeGroot LJ
Clin Immunol Immunopathol; 1997 Dec; 85(3):253-64. PubMed ID: 9400625
[TBL] [Abstract][Full Text] [Related]
25. Thyroid autoantigen-induced lymphocyte proliferation in Graves' disease and Hashimoto's thyroiditis.
Weetman AP; Gunn C; Hall R; McGregor AM
J Clin Lab Immunol; 1985 May; 17(1):1-6. PubMed ID: 3876444
[TBL] [Abstract][Full Text] [Related]
26. Changes in Th1/Th2 cytokine balance in Graves' disease.
Kocjan T; Wraber B; Repnik U; Hojker S
Pflugers Arch; 2000; 440(5 Suppl):R94-5. PubMed ID: 11005626
[TBL] [Abstract][Full Text] [Related]
27. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
[TBL] [Abstract][Full Text] [Related]
28. Cytokine profiles of in vivo activated thyroid-infiltrating T cells cloned in the presence or absence of interleukin 4.
Guo J; Rapoport B; McLachlan SM
Autoimmunity; 1997; 26(2):103-10. PubMed ID: 9546811
[TBL] [Abstract][Full Text] [Related]
29. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR).
Heuer M; Aust G; Ode-Hakim S; Scherbaum WA
Thyroid; 1996 Apr; 6(2):97-106. PubMed ID: 8733879
[TBL] [Abstract][Full Text] [Related]
30. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
Nanba T; Watanabe M; Inoue N; Iwatani Y
Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
[TBL] [Abstract][Full Text] [Related]
31. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis.
Kemp EH; Ajjan RA; Metcalfe RA; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2015 Nov; 83(5):726-32. PubMed ID: 25940130
[TBL] [Abstract][Full Text] [Related]
32. Suppressor T-lymphocyte deficiency in Graves' disease and Hashimoto's thyroiditis.
Okita N; Row VV; Volpe R
J Clin Endocrinol Metab; 1981 Mar; 52(3):528-33. PubMed ID: 6450775
[TBL] [Abstract][Full Text] [Related]
33. Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
Solerte SB; Precerutti S; Gazzaruso C; Locatelli E; Zamboni M; Schifino N; Bonacasa R; Rondanelli M; Taccani D; Ferrari E; Fioravanti M
Eur J Endocrinol; 2005 May; 152(5):703-12. PubMed ID: 15879355
[TBL] [Abstract][Full Text] [Related]
34. Analysis of cytokine gene expression in Graves' disease and multinodular goiter.
Watson PF; Pickerill AP; Davies R; Weetman AP
J Clin Endocrinol Metab; 1994 Aug; 79(2):355-60. PubMed ID: 8045947
[TBL] [Abstract][Full Text] [Related]
35. CXCR6 within T-helper (Th) and T-cytotoxic (Tc) type 1 lymphocytes in Graves' disease (GD).
Aust G; Kamprad M; Lamesch P; Schmücking E
Eur J Endocrinol; 2005 Apr; 152(4):635-43. PubMed ID: 15817921
[TBL] [Abstract][Full Text] [Related]
36. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins.
Stassi G; Di Liberto D; Todaro M; Zeuner A; Ricci-Vitiani L; Stoppacciaro A; Ruco L; Farina F; Zummo G; De Maria R
Nat Immunol; 2000 Dec; 1(6):483-8. PubMed ID: 11101869
[TBL] [Abstract][Full Text] [Related]
37. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis.
Paschke R; Schuppert F; Taton M; Velu T
J Endocrinol; 1994 May; 141(2):309-15. PubMed ID: 8046301
[TBL] [Abstract][Full Text] [Related]
38. The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis.
Weetman AP; Volkman DJ; Burman KD; Margolick JB; Petrick P; Weintraub BD; Fauci AS
Clin Immunol Immunopathol; 1986 Apr; 39(1):139-50. PubMed ID: 3485022
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of antigen receptor variable region repertoires in T lymphocytes infiltrating the intrathyroidal and extrathyroidal manifestations in patients with Graves' disease.
Heufelder AE; Schworm HD; Wenzel BE; Garrity JA; Bahn RS
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():84-7. PubMed ID: 8981009
[TBL] [Abstract][Full Text] [Related]
40. Graves' disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells.
Leskela S; Serrano A; de la Fuente H; Rodríguez-Muñoz A; Ramos-Levi A; Sampedro-Nuñez M; Sánchez-Madrid F; González-Amaro R; Marazuela M
PLoS One; 2015; 10(4):e0123938. PubMed ID: 25880730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
